Healthcare Infection Control Practices Advisory Committee (HICPAC), 34437 [2015-14751]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 115 / Tuesday, June 16, 2015 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–14709 Filed 6–15–15; 8:45 am]
both CDC and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2015–14751 Filed 6–15–15; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
asabaliauskas on DSK5VPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting for the
aforementioned committee:
Times and Dates:
9:00 a.m.–5:00 p.m., July 16, 2015
9:00 a.m.–12:00 p.m., July 17, 2015
Place: CDC, 1600 Clifton Rd., Global
Communications Center, Building 19,
Auditorium B, Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available. Please register for the
meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with
providing advice and guidance to the
Director, Division of Healthcare Quality
Promotion, the Director, National Center for
Emerging and Zoonotic Infectious Diseases
(NCEZID), the Director, CDC, and the
Secretary, Health and Human Services
regarding (1) the practice of healthcare
infection prevention and control; (2)
strategies for surveillance, prevention, and
control of infections, antimicrobial
resistance, and related events in settings
where healthcare is provided; and (3)
periodic updating of CDC guidelines and
other policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters for Discussion: The agenda will
include updates on CDC’s activities for
prevention and control of healthcare
associated infections (HAIs), updates on
hospital antimicrobial stewardship activities,
an update on Draft Guideline to Prevent
Surgical Site Infections, infection control
practice improvements, and environmental
infection control.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Erin
Stone, M.S., HICPAC, Division of Healthcare
Quality Promotion, NCEZID, CDC, l600
Clifton Road NE., Mailstop A–07, Atlanta,
Georgia 30333 Telephone (404) 639–4045.
Email: hicpac@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
VerDate Sep<11>2014
17:18 Jun 15, 2015
Jkt 235001
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 80 FR 30076, dated
May 26, 2015) is amended to reflect the
reorganization of the National Institute
for Occupational Safety and Health,
Centers for Disease Control and
Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete in its entirety the title and the
mission and function statements for the
National Personal Protective
Technology Laboratory (CCL) and insert
the following:
The National Personal Protective
Technology (NPPTL) (CCL) prevents
work-related injury, illness and death by
advancing the state of knowledge and
application of personal protective
technologies (PPT) including
instrumentation, respiratory protective
devices (RPD), and a diversity of
personal protective equipment (PPE)
used for the protection of American
workers. To accomplish this mission,
NPPTL leads and coordinates the
National Institute for Occupational
Safety and Health’s (NIOSH) programs,
projects, and policies related to PPT
across the Institute. NPPTL: (1)
Identifies the need for research,
conducts and coordinates research to
support the development of new
technologies, performance, quality and
reliability standards, Federal
regulations, safety and health criteria,
and Institute policy; (2) conducts a
variety of laboratory and field
investigations relating to the
development and evaluation of
innovative technologies; (3) directs,
implements, and provides national
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
34437
guidance related to conformity
assessment programs and functions (e.g.
inspection, testing, certification, quality
assurance, surveillance); (4) provides
national leadership serving on national
and international PPT consensus
standard setting committees; (5)
develops and promulgates standards
and regulations; (6) produces and
disseminates scientific reports and
national guidance documents including
research, laboratory and field studies,
safety and health investigations,
scientific criteria, and national
guidance; (7) designs and implements
information technology functions
including national or program
databases, trusted sources for public
information and social marketing; and
(8) coordinates program support
functions including budget, facilities,
growth initiatives, and communications,
and scientific support functions such as
Committee on Personal Protective
Equipment and Institute of Medicine
evaluations, special projects, nonrespiratory PPE conformity assessment,
and federal and consensus standards
across NIOSH.
Research Branch (CCLE). (1) Conducts
hypothesis testing-based PPT research
with an emphasis on respiratory
protection, protective clothing, and
ensemble research; (2) encourages and
conducts research related to innovative
technologies to improve the use and
usability of existing and new PPT
products; (3) conducts laboratory and
field research projects to measure
performance, quality, reliability, and
efficacy of the materials, components,
and sub-systems used in PPT as well as
complete equipment systems, especially
for new or emerging hazards, and
recommends criteria to improve the
selection, care, maintenance, and use of
PPT; (4) investigates emerging hazards
and personal exposures to identify
worker PPT needs and technology gaps;
(5) conducts research to identify and
recommend effective integration
strategies and evidence-based test
methods for PPT for use in PPT
standards; (6) recommends
performance, quality, reliability, and
efficacy criteria; (7) studies and
improves human/technology interfaces
to better understand and mitigate
barriers to effective PPT selection, care,
maintenance, and use; (8) conducts
laboratory and field-based research into
the biomechanical, physiological, and
psychological stressors and worker
responses to PPT; (9) conducts research,
developing interventions, and identifies
innovative methods (e.g., new software
tools, information technology, social
marketing, training methods, practices,
E:\FR\FM\16JNN1.SGM
16JNN1
]]>Agencies
[Federal Register Volume 80, Number 115 (Tuesday, June 16, 2015)]
[Notices]
[Page 34437]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-14751]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following meeting for the aforementioned
committee:
Times and Dates:
9:00 a.m.-5:00 p.m., July 16, 2015
9:00 a.m.-12:00 p.m., July 17, 2015
Place: CDC, 1600 Clifton Rd., Global Communications Center,
Building 19, Auditorium B, Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Please register for the meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion,
the Director, National Center for Emerging and Zoonotic Infectious
Diseases (NCEZID), the Director, CDC, and the Secretary, Health and
Human Services regarding (1) the practice of healthcare infection
prevention and control; (2) strategies for surveillance, prevention,
and control of infections, antimicrobial resistance, and related
events in settings where healthcare is provided; and (3) periodic
updating of CDC guidelines and other policy statements regarding
prevention of healthcare-associated infections and healthcare-
related conditions.
Matters for Discussion: The agenda will include updates on CDC's
activities for prevention and control of healthcare associated
infections (HAIs), updates on hospital antimicrobial stewardship
activities, an update on Draft Guideline to Prevent Surgical Site
Infections, infection control practice improvements, and
environmental infection control.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Erin Stone, M.S., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton
Road NE., Mailstop A-07, Atlanta, Georgia 30333 Telephone (404) 639-
4045. Email: hicpac@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2015-14751 Filed 6-15-15; 8:45 am]
BILLING CODE 4163-18-P
